Circulating levels of the cytokines IL10, IFNγ and resistin in an obese mouse model of developmental programming

Journal of Developmental Origins of Health and Disease

Volumn 4, Issue 6, 2013, Pages 491-498

  Keepczynska M A ^a   Wargent, E T ^a   Cawthorne, M A ^a   Arch, J R S ^a   O'Dowd, J F ^a   Stocker, C J ^a  

^a UNIVERSITY OF BUCKINGHAM   (United Kingdom)

Author keywords

cytokines; developmental programming; maternal obesity; metabolic disease; overnutrition

Indexed keywords

EID: 84887649932     PISSN: 20401744     EISSN: 20401752     Source Type: Journal    
DOI: 10.1017/S2040174413000263     Document Type: Article

References (62)

1. Franks PW, Hanson RL, Knowler WC, et al. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010; 362, 485-493
2. Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH. Predicting obesity in young adulthood from childhood and parental obesity. N Engl J Med. 1997; 337, 869-873
3. Catalano PM, Farrell K, Thomas A, et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr. 2009; 90, 1303-1313
4. Whitaker KL, Jarvis MJ, Beeken RJ, Boniface D, Wardle J. Comparing maternal and paternal intergenerational transmission of obesity risk in a large population-based sample. Am J Clin Nutr. 2010; 91, 1560-1567
5. Pirkola J, Pouta A, Bloigu A, et al. Risks of overweight and abdominal obesity at age 16 years associated with prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus. Diabetes Care. 2010; 33, 1115-1121
6. Koupil I, Toivanen P. Social and early-life determinants of overweight and obesity in 18-year-old Swedish men. Int J Obes (Lond). 2008; 32, 73-81
7. Mingrone G, Manco M, Mora ME, Guidone C, Iaconelli A, Gniuli D, Leccesi L, Chiellini C, Ghirlanda G. Influence of maternal obesity on insulin sensitivity and secretion in the offspring. Diabetes Care. 2008; 31, 1872-1876
8. Reynolds RM, Osmond C, Phillips DI, Godfrey KM. Maternal BMI, parity, and pregnancy weight gain: Influences on offspring adiposity in young adulthood. J Clin Endocrinol Metab. 2010;95, 5365-5369
9. Lawlor DA, Smith GD, O'Callaghan M, et al. Epidemiologic evidence for the fetal overnutrition hypothesis: Findings from the mater-university study of pregnancy and its outcomes. Am J Epidemiol. 2007; 165, 418-424
10. Nelson SM, Matthews P, Poston L. Maternal metabolism and obesity: Modifiable determinants of pregnancy outcome. Hum Reprod Update. 2010; 16, 255-275
11. Dabelea D. The predisposition to obesity and diabetes in offspring of diabetic mothers. Diabetes Care. 2007; 30(Suppl 2), S169-S174
12. Hillier TA, Pedula KL, Schmidt MM, et al. Childhood obesity and metabolic imprinting: The ongoing effects of maternal hyperglycemia. Diabetes Care. 2007; 30, 2287-2292
13. Hyperglycemia and Adverse Pregnancy Outcome (HAPO). Study: Associations with neonatal anthropometrics. Diabetes. 2009; 58, 453-459
14. Silverman BL, Metzger BE, Cho NH, Loeb CA. Impaired glucose tolerance in adolescent offspring of diabetic mothers. Relationship to fetal hyperinsulinism. Diabetes Care. 1995; 18, 611-617
15. Herrera E, Amusquivar E. Lipid metabolism in the fetus and the newborn. Diabetes Metab Res Rev. 2000; 16, 202-210
16. Hamilton JK, Odrobina E, Yin J, et al.Maternal insulin sensitivity during pregnancy predicts infant weight gain and adiposity at 1 year of age. Obesity (Silver Spring). 2010; 18, 340-346
17. Stocker CJ, Cawthorne MA. The influence of leptin on early life programming of obesity. Trends Biotechnol. 2008; 26, 545-551
18. Briana DD, Malamitsi-Puchner A. The role of adipocytokines in fetal growth. Ann N Y Acad Sci. 2010; 1205, 82-87
19. Heerwagen MJ, Miller MR, Barbour LA, Friedman JE. Maternal obesity and fetal metabolic programming: A fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol. 2010; 299, R711-R722
20. Poston L. Developmental programming and diabetes - the human experience and insight from animal models. Best Pract Res Clin Endocrinol Metab. 2010; 24, 541-552
21. Bayol SA, Simbi BH, Bertrand JA, Stickland NC. Offspring from mothers fed a 'junk food' diet in pregnancy and lactation exhibit exacerbated adiposity that is more pronounced in females. J Physiol. 2008; 586, 3219-3230
22. Nivoit P, Morens C, Van Assche FA, et al. Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance. Diabetologia. 2009; 52, 1133-1142
23. Samuelsson AM, Matthews PA, Argenton M, et al. Dietinduced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: A novel murine model of developmental programming. Hypertension. 2008; 51, 383-392
24. Plagemann A, Harder T, Kohlhoff R, Rohde W, Dorner G. Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes. Int J Obes Relat Metab Disord. 1997; 21, 451-456
25. Farley D, Tejero ME, Comuzzie AG, et al. Feto-placental adaptations to maternal obesity in the baboon. Placenta. 2009;30, 752-760
26. Strakovsky RS, Pan YX. A decrease in DKK1, a WNT inhibitor, contributes to placental lipid accumulation in an obesity-prone rat model. Biol Reprod. 2012; 86, 81
27. McCurdy CE, Bishop JM, Williams SM, et al. Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest. 2009; 119, 323-335
28. Odaka Y, Nakano M, Tanaka T, et al. The influence of a high-fat dietary environment in the fetal period on postnatal metabolic and immune function. Obesity (Silver Spring). 2010;18, 1688-1694
29. Bourlier V, Bouloumie A. Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab. 2009; 35, 251-260
30. de Luca C, Olefsky JM. Inflammation and insulin resistance. FEBS Lett. 2008; 582, 97-105
31. Catalano PM, Presley L, Minium J, Hauguel-de Mouzon S. Fetuses of obese mothers develop insulin resistance in utero. Diabetes Care. 2009; 32, 1076-1080
32. Grayson BE, Levasseur PR, Williams SM, et al. Changes in melanocortin expression and inflammatory pathways in fetal offspring of nonhuman primates fed a high-fat diet. Endocrinology. 2010; 151, 1622-1632
33. Urbanek M, Hayes MG, Lee H, et al. The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy. PLoS One. 2012; 7, e32958
34. Dahlgren J, Samuelsson AM, Jansson T, Holmang A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res. 2006; 60, 147-151
35. Lager S, Asterholm IW, Schele E, et al. Perinatal lack of maternal IL-6 promotes increased adiposity during adulthood in mice. Endocrinology. 2011; 152, 1336-1346
36. Zhu MJ, Ma Y, Long NM, Du M, Ford SP. Maternal obesity markedly increases placental fatty acid transporter expression and fetal blood triglycerides at midgestation in the ewe. Am J Physiol Regul Integr Comp Physiol. 2010; 299, R1224-R1231
37. Howie GJ, Sloboda DM, Kamal T, Vickers MH. Maternal nutritional history predicts obesity in adult offspring independent of postnatal diet. J Physiol. 2009; 587(Pt 4), 905-915
38. Jones HN, Woollett LA, Barbour N, et al. High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57/BL6 mice. Faseb J. 2009; 23, 271-278
39. Zambrano E, Martinez-Samayoa PM, Rodriguez-Gonzalez GL, Nathanielsz PW. Dietary intervention prior to pregnancy reverses metabolic programming in male offspring of obese rats. J Physiol. 2010; 588(Pt 10), 1791-1799
40. Hulsmans M, Van Dooren E, Mathieu C, Holvoet P. Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin. PLoS One. 2012; 7, e32794
41. Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005; 90, 4542-4548
42. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005; 174, 5789-5795
43. Rajala MW, Qi Y, Patel HR, et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes. 2004; 53, 1671-1679
44. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature. 2001; 409, 307-312
45. Heilbronn LK, Rood J, Janderova L, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab. 2004; 89, 1844-1848
46. Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferatoractivated receptor-gamma action in humans. Diabetes. 2001; 50, 2199-2202
47. Way JM, Gorgun CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator- activated receptor gamma agonists. J Biol Chem. 2001; 276, 25651-25653
48. Caja S, Martinez I, Abelenda M, Puerta M. Resistin expression and plasma concentration peak at different times during pregnancy in rats. J Endocrinol. 2005; 185, 551-559
49. Megia A, Vendrell J, Gutierrez C, et al. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol. 2008; 158, 173-178
50. Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH. Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies. Metabolism. 2012; 61, 699-705
51. Cho GJ, Yoo SW, Hong SC, et al. Correlations between umbilical and maternal serum resistin levels and neonatal birth weight. Acta Obstet Gynecol Scand. 2006; 85, 1051-1056
52. Savino F, Liguori SA, Fissore MF, Oggero R. Breast milk hormones and their protective effect on obesity. Int J Pediatr Endocrinol. 2009; 2009, 327505
53. Chan TF, Tsai YC, Wu CH, et al. The positive correlation between cord serum retinol-binding protein 4 concentrations and fetal growth. Gynecol Obstet Invest. 2011; 72, 98-102
54. Laudes M, Oberhauser F, Bilkovski R, et al. Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity. Exp Clin Endocrinol Diabetes. 2009; 117, 146-149
55. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005; 436, 356-362
56. Esposito K, Pontillo A, Giugliano F, et al. Association of low interleukin-10 levels with the metabolic syndrome in obese women. J Clin Endocrinol Metab. 2003; 88, 1055-1058
57. Juge-Aubry CE, Somm E, Pernin A, et al. Adipose tissue is a regulated source of interleukin-10. Cytokine. 2005; 29, 270-274
58. Renaud SJ, Macdonald-Goodfellow SK, Graham CH. Coordinated regulation of human trophoblast invasiveness by macrophages and interleukin 10. Biol Reprod. 2007; 76, 448-454
59. Bugatto F, Fernandez-Deudero A, Bailen A, et al. Secondtrimester amniotic fluid proinflammatory cytokine levels in normal and overweight women. Obstet Gynecol. 2010; 115, 127-133
60. Ramsay JE, Ferrell WR, Crawford L, et al. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab. 2002; 87, 4231-4237
61. White CL, Purpera MN, Morrison CD. Maternal obesity is necessary for programming effect of high-fat diet on offspring. Am J Physiol Regul Integr Comp Physiol. 2009; 296, R1464-R1472
62. Farah N, Hogan AE, O'Connor N, et al. Correlation between maternal inflammatory markers and fetomaternal adiposity. Cytokine. 2012; 60, 96-99